Genetic influence on variation in serum uric acid in American Indians: the strong heart family study
暂无分享,去创建一个
L. Almasy | B. Howard | R. Devereux | S. Cole | J. Maccluer | N. Franceschini | H. Göring | A. Comuzzie | R. Fabsitz | L. Best | S. Laston | Elisa Lee | V. Voruganti | K. Haack | A. Mottl | J. Umans | V. S. Voruganti | R. B. Devereux | V. Saroja Voruganti | Jean W. MacCluer | Richard R. Fabsitz | Jason G. Umans | Amy K. Mottl | S. Cole
[1] W. Pan,et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. , 2009, Arthritis and rheumatism.
[2] J. Blangero,et al. Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican Americans. , 2009, The Journal of clinical endocrinology and metabolism.
[3] B. Rovin,et al. Uric acid and cardiovascular risk. , 2009, The New England journal of medicine.
[4] G. Curhan,et al. Uric acid and insulin sensitivity and risk of incident hypertension. , 2009, Archives of internal medicine.
[5] Y. Kikuchi,et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. , 2008, American journal of human genetics.
[6] A. Hofman,et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study , 2008, The Lancet.
[7] J. Choe,et al. T6092C polymorphism of SLC22A12 gene is associated with serum uric acid concentrations in Korean male subjects. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[8] H. Yoon,et al. Prevalence of hypouricaemia and SLC22A12 mutations in healthy Korean subjects , 2008, Nephrology.
[9] M. Bachmann,et al. Vaccination against GIP for the Treatment of Obesity , 2008, PloS one.
[10] I. Hisatome,et al. Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese , 2008, Clinical genetics.
[11] Giuseppe Lippi,et al. High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes , 2008, Diabetes Care.
[12] F. Kronenberg,et al. Sex-Specific Association of the Putative Fructose Transporter SLC2A9 Variants With Uric Acid Levels Is Modified by BMI , 2008, Diabetes Care.
[13] S. Wiedmann,et al. Association of Common Polymorphisms in GLUT9 Gene with Gout but Not with Coronary Artery Disease in a Large Case-Control Study , 2008, PloS one.
[14] J. Shaw,et al. Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. , 2008, Metabolic syndrome and related disorders.
[15] Mario Falchi,et al. Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia , 2022 .
[16] F. Kronenberg,et al. The gender-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI , 2008 .
[17] C. Gieger,et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects , 2008, Nature Genetics.
[18] William A. Richardson,et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout , 2008, Nature Genetics.
[19] J. Blangero,et al. Genome scan for determinants of serum uric acid variability. , 2007, Journal of the American Society of Nephrology : JASN.
[20] S. Bandinelli,et al. The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts , 2007, PLoS genetics.
[21] L. Kuller,et al. Hyperuricemia and Incidence of Hypertension Among Men Without Metabolic Syndrome , 2007, Hypertension.
[22] T. Hosoya,et al. Relationship between hyperuricemia and body fat distribution. , 2007, Internal medicine.
[23] W. Sato,et al. Uric acid, the metabolic syndrome, and renal disease. , 2006, Journal of the American Society of Nephrology : JASN.
[24] D. Mikhailidis,et al. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? , 2006, Metabolism: clinical and experimental.
[25] A. Onat,et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. , 2006, American journal of hypertension.
[26] T. Srinivas,et al. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. , 2006, Kidney international.
[27] L. Almasy,et al. Linkage analysis of LDL cholesterol in American Indian populations: the Strong Heart Family Study s⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional figures. Published, JLR Papers in Press, November 1, 2005. , 2006, Journal of Lipid Research.
[28] W Greg Miller,et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. , 2006, Clinical chemistry.
[29] K. Tuttle,et al. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome , 2005, Nature Clinical Practice Nephrology.
[30] S. Wannamethee,et al. Serum uric acid and risk of coronary heart disease. , 2005, Current pharmaceutical design.
[31] D. Levy,et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. , 2005, Metabolism: clinical and experimental.
[32] Byung Jin Kim,et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[33] J. H. Acosta,et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? , 2005, Journal of the American Society of Nephrology : JASN.
[34] E. Block,et al. Hyperuricemia induces endothelial dysfunction. , 2005, Kidney international.
[35] Y. Kikuchi,et al. Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. , 2005, The Journal of clinical endocrinology and metabolism.
[36] Tsutomu Takahashi,et al. Recurrent URAT1 gene mutations and prevalence of renal hypouricemia in Japanese , 2005, Pediatric Nephrology.
[37] H. Simmonds,et al. Hereditary hyperuricemia and renal disease. , 2005, Seminars in nephrology.
[38] S. Tyagi,et al. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle , 2004, Nutrition & metabolism.
[39] A. Enomoto,et al. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia , 2004, Pediatric Nephrology.
[40] D. Conen,et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country , 2004, BMC public health.
[41] A. J. Reyes. Cardiovascular Drugs and Serum Uric Acid , 2003, Cardiovascular Drugs and Therapy.
[42] Y. Friedlander,et al. Family resemblance for serum uric acid in a Jerusalem sample of families , 1988, Human Genetics.
[43] D. Rao,et al. The cincinnati lipid research clinic family study: Familial determinants of plasma uric acid , 2004, Human Genetics.
[44] J. Pankow,et al. Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. , 2003, Diabetes.
[45] K. Tuttle,et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? , 2003, Hypertension.
[46] B. Howard,et al. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. , 2003, American journal of epidemiology.
[47] A. Schoolwerth,et al. Part 1. Uric acid and losartan , 2002, Current opinion in nephrology and hypertension.
[48] D. Gudbjartsson,et al. A high-resolution recombination map of the human genome , 2002, Nature Genetics.
[49] Hirotaka Matsuo,et al. Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.
[50] Mary Sara McPeek,et al. Enhanced Pedigree Error Detection , 2002, Human Heredity.
[51] C. Antignac,et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. , 2000, Journal of the American Society of Nephrology : JASN.
[52] I. Borecki,et al. Segregation analysis of serum uric acid in the NHLBI Family Heart Study , 2000, Human Genetics.
[53] B. Howard,et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. , 1999, Circulation.
[54] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[55] W. Rathmann,et al. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. , 1998, Annals of epidemiology.
[56] L. Almasy,et al. Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.
[57] L. Niskanen,et al. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. , 1998, Stroke.
[58] O. Pedersen,et al. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. , 1998, European journal of endocrinology.
[59] T. Mansfield,et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III , 1997, Nature Genetics.
[60] S. Heath. Markov chain Monte Carlo segregation and linkage analysis for oligogenic models. , 1997, American journal of human genetics.
[61] L. Almasy,et al. Multipoint oligogenic linkage analysis of quantitative traits , 1997, Genetic epidemiology.
[62] F. Marumo,et al. Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization. , 1996, Genomics.
[63] K Lange,et al. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. , 1996, American journal of human genetics.
[64] T. Byers,et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. , 1995, American journal of epidemiology.
[65] J. Edmonds,et al. Familial hyperuricemic nephropathy. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[66] T. Rice,et al. Heterogeneity in the familial aggregation of fasting serum uric acid level in five North American populations: the Lipid Research Clinics Family Study. , 1990, American journal of medical genetics.
[67] M. Blaufox,et al. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. , 1987, Archives of internal medicine.
[68] D. Rao,et al. The Clinical Lipid Research Clinic Family Study: familial determinants of plasma uric acid. , 1982, Human genetics.
[69] J. Gill,et al. Gout as a complication of Bartter's syndrome. A possible role for alkalosis in the decreased clearance of uric acid. , 1975, Annals of internal medicine.
[70] J. Meslin,et al. [Effect of dietary magnesium levels on cardiac lesions in rats fed a diet rich in rapeseed oil]. , 1975, Nutrition and metabolism.
[71] H. Schlicke,et al. A colorimetric method using uricase and peroxidase for the determination of uric acid. , 1968, Analytical biochemistry.
[72] H. Valkenburg,et al. THE DISTRIBUTION OF SERUM URIC ACID VALUES IN A POPULATION UNSELECTED AS TO GOUT OR HYPERURICEMIA: TECUMSEH, MICHIGAN 1959-1960. , 1965 .
[73] Dixon As. Familial hyperuricaemic nephropathy. , 1960 .
[74] A. H. Hersh,et al. The heredity of gout and its relationship to familial hyperuricemia. , 1949, Annals of internal medicine.